{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T04:20:56Z","timestamp":1790742056716,"version":"4.1.0"},"reference-count":280,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Immunobiology"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.imbio.2023.152413","type":"journal-article","created":{"date-parts":[[2023,8,18]],"date-time":"2023-08-18T15:50:29Z","timestamp":1692373829000},"page":"152413","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["The role of C5a receptors in autoimmunity"],"prefix":"10.1016","volume":"228","author":[{"given":"Jovan","family":"Schanzenbacher","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katja","family":"Hendrika K\u00e4hler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evelyn","family":"Mesler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Kleingarn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Marcel Karsten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Leonard Seiler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.imbio.2023.152413_b0005","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/s41577-021-00665-1","article-title":"The state of complement in COVID-19","volume":"22","author":"Afzali","year":"2022","journal-title":"Nature Reviews Immunology"},{"issue":"11","key":"10.1016\/j.imbio.2023.152413_b0010","doi-asserted-by":"crossref","first-page":"S2300","DOI":"10.1016\/j.jtho.2017.09.1698","article-title":"P3.07-007 blockade of the complement C5a\/C5aR1 axis impairs lung cancer bone metastasis","volume":"12","author":"Ajona","year":"2017","journal-title":"Journal of Thoracic Oncology"},{"issue":"7","key":"10.1016\/j.imbio.2023.152413_b0015","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1002\/eji.201546131","article-title":"A novel \u201ccomplement\u2013metabolism\u2013inflammasome axis\u201d as a key regulator of immune cell effector function","volume":"46","author":"Arbore","year":"2016","journal-title":"European Journal of Immunology"},{"issue":"6292","key":"10.1016\/j.imbio.2023.152413_b0020","doi-asserted-by":"crossref","first-page":"aad1210","DOI":"10.1126\/science.aad1210","article-title":"T helper 1 immunity requires complement-driven NLRP3 inflammasome activity in CD4+ T cells","volume":"352","author":"Arbore","year":"2016","journal-title":"Science"},{"issue":"5","key":"10.1016\/j.imbio.2023.152413_b0025","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1111\/pai.13060","article-title":"A randomized trial of human C1 inhibitor prophylaxis in children with hereditary angioedema","volume":"30","author":"Ayg\u00f6ren-P\u00fcrs\u00fcn","year":"2019","journal-title":"Pediatric Allergy and Immunology"},{"issue":"10","key":"10.1016\/j.imbio.2023.152413_b0030","doi-asserted-by":"crossref","first-page":"7633","DOI":"10.1074\/jbc.M109.092106","article-title":"The C5a receptor (C5aR) C5L2 is a modulator of C5aR-mediated signal transduction","volume":"285","author":"Bamberg","year":"2010","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/j.imbio.2023.152413_b0035","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.4049\/jimmunol.1102310","article-title":"Role of C3a receptors, C5a receptors, and complement protein C6 deficiency in collagen antibody-induced arthritis in mice","volume":"188","author":"Banda","year":"2012","journal-title":"The Journal of Immunology"},{"issue":"8","key":"10.1016\/j.imbio.2023.152413_b0040","doi-asserted-by":"crossref","first-page":"2496","DOI":"10.1002\/eji.200526327","article-title":"C5a promotes development of experimental lupus nephritis which can be blocked with a specific receptor antagonist","volume":"35","author":"Bao","year":"2005","journal-title":"European Journal of Immunology"},{"issue":"4","key":"10.1016\/j.imbio.2023.152413_b0045","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1073\/pnas.1316877111","article-title":"C3 opsonization regulates endocytic handling of apoptotic cells resulting in enhanced T-cell responses to cargo-derived antigens","volume":"111","author":"Baudino","year":"2014","journal-title":"Proceedings of the National Academy of Sciences"},{"issue":"11","key":"10.1016\/j.imbio.2023.152413_b0050","doi-asserted-by":"crossref","DOI":"10.1097\/CCE.0000000000000577","article-title":"Efficacy and safety of vilobelimab (IFX-1), a novel monoclonal anti-C5a antibody, in patients with early severe sepsis or septic shock \u2014 A randomized, placebo-controlled, double-blind, multicenter, phase IIa trial (SCIENS study)","volume":"3","author":"Bauer","year":"2021","journal-title":"Critical Care Explorations"},{"key":"10.1016\/j.imbio.2023.152413_b0055","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1093\/brain\/awp322","article-title":"Quantitative analysis of cellular inflammation after traumatic spinal cord injury: Evidence for a multiphasic inflammatory response in the acute to chronic environment","volume":"133","author":"Beck","year":"2010","journal-title":"Brain: A Journal of Neurology"},{"key":"10.1016\/j.imbio.2023.152413_b0060","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2022.811504","article-title":"Complement mediated endothelial damage in thrombotic microangiopathies","volume":"9","author":"Blasco","year":"2022","journal-title":"Frontiers in Medicine"},{"issue":"2, Supplement","key":"10.1016\/j.imbio.2023.152413_b0065","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.1016\/j.ekir.2022.01.124","article-title":"Effect of avacopan, a selective C5a receptor inhibitor, on complement 3 glomerulopathy histologic index of disease chronicity","volume":"7","author":"Bomback","year":"2022","journal-title":"Kidney International Reports"},{"issue":"10","key":"10.1016\/j.imbio.2023.152413_b0070","doi-asserted-by":"crossref","first-page":"5086","DOI":"10.4049\/jimmunol.1102914","article-title":"Complement activation product C5a is a selective suppressor of TLR4-induced, but not TLR3-induced, production of IL-27(p28) from macrophages","volume":"188","author":"Bosmann","year":"2012","journal-title":"Journal of Immunology"},{"issue":"7","key":"10.1016\/j.imbio.2023.152413_b0075","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1002\/eji.201243075","article-title":"The interaction between C5a and both C5aR and C5L2 receptors is required for production of G-CSF during acute inflammation","volume":"43","author":"Bosmann","year":"2013","journal-title":"European Journal of Immunology"},{"issue":"1, Part 1","key":"10.1016\/j.imbio.2023.152413_b0080","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/S0002-9378(11)90700-5","article-title":"Immunoglobulin G fractions from patients with antiphospholipid antibodies cause fetal death in BALB\/c mice: A model for autoimmune fetal loss","volume":"163","author":"Branch","year":"1990","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"6","key":"10.1016\/j.imbio.2023.152413_b0085","doi-asserted-by":"crossref","first-page":"4277","DOI":"10.1074\/jbc.M210120200","article-title":"Phosphorylation of key serine residues is required for internalization of the complement 5a (C5a) anaphylatoxin receptor via a \u03b2-arrestin, dynamin, and clathrin-dependent pathway","volume":"278","author":"Braun","year":"2003","journal-title":"Journal of Biological Chemistry"},{"issue":"5","key":"10.1016\/j.imbio.2023.152413_b0090","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1046\/j.1523-1755.1998.00155.x","article-title":"Cultured human glomerular mesangial cells express the C5a receptor","volume":"54","author":"Braun","year":"1998","journal-title":"Kidney International"},{"issue":"16","key":"10.1016\/j.imbio.2023.152413_b0095","doi-asserted-by":"crossref","first-page":"6517","DOI":"10.1523\/JNEUROSCI.5218-14.2015","article-title":"The complement receptor C5aR controls acute inflammation and astrogliosis following spinal cord injury","volume":"35","author":"Brennan","year":"2015","journal-title":"The Journal of Neuroscience"},{"key":"10.1016\/j.imbio.2023.152413_b0105","doi-asserted-by":"crossref","first-page":"258","DOI":"10.3389\/fimmu.2018.00258","article-title":"A novel role for C5a in B-1 cell homeostasis","volume":"9","author":"Br\u00f6ker","year":"2018","journal-title":"Frontiers in Immunology"},{"issue":"5","key":"10.1016\/j.imbio.2023.152413_b0110","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1093\/ckj\/sfab294","article-title":"C5a receptor inhibitor avacopan in immunoglobulin A nephropathy\u2014An open-label pilot study","volume":"15","author":"Bruchfeld","year":"2022","journal-title":"Clinical Kidney Journal"},{"issue":"1","key":"10.1016\/j.imbio.2023.152413_b0115","first-page":"132","article-title":"US HAEA medical advisory board 2020 guidelines for the management of hereditary angioedema","volume":"9","author":"Busse","year":"2021","journal-title":"The Journal of Allergy and Clinical Immunology: In Practice"},{"issue":"9","key":"10.1016\/j.imbio.2023.152413_b0120","doi-asserted-by":"crossref","first-page":"7165","DOI":"10.1074\/jbc.C100714200","article-title":"The orphan receptor C5L2 has high affinity binding sites for complement fragments C5a and C5a des-Arg(74)","volume":"277","author":"Cain","year":"2002","journal-title":"The Journal of Biological Chemistry"},{"issue":"12","key":"10.1016\/j.imbio.2023.152413_b0125","doi-asserted-by":"crossref","first-page":"C1731","DOI":"10.1152\/ajpcell.00213.2011","article-title":"Human colonic epithelial cells detect and respond to C5a via apically expressed C5aR through the ERK pathway","volume":"302","author":"Cao","year":"2012","journal-title":"American Journal of Physiology-Cell Physiology"},{"issue":"14","key":"10.1016\/j.imbio.2023.152413_b0130","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1177\/0961203312458839","article-title":"C6 knock-out mice are protected from thrombophilia mediated by antiphospholipid antibodies","volume":"21","author":"Carrera-Mar\u00edn","year":"2012","journal-title":"Lupus"},{"issue":"7836","key":"10.1016\/j.imbio.2023.152413_b0135","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1038\/s41586-020-2600-6","article-title":"Association of COVID-19 inflammation with activation of the C5a\u2013C5aR1 axis","volume":"588","author":"Carvelli","year":"2020","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.imbio.2023.152413_b0140","doi-asserted-by":"crossref","first-page":"928","DOI":"10.4049\/jimmunol.136.3.928","article-title":"T cell lines mediating experimental autoimmune uveoretinitis (EAU) in the rat","volume":"136","author":"Caspi","year":"1986","journal-title":"Journal of Immunology"},{"key":"10.1016\/j.imbio.2023.152413_b0145","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.841785","article-title":"Beyond systemic lupus erythematosus and anti-phospholipid syndrome: the relevance of complement from pathogenesis to pregnancy outcome in other systemic rheumatologic diseases","volume":"13","author":"Cavalli","year":"2022","journal-title":"Frontiers in Pharmacology"},{"issue":"4","key":"10.1016\/j.imbio.2023.152413_b0150","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1182\/blood.2019003863","article-title":"Complement activity and complement regulatory gene mutations are associated with thrombosis in APS and CAPS","volume":"135","author":"Chaturvedi","year":"2020","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.imbio.2023.152413_b0155","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1111\/jth.15082","article-title":"Antiphospholipid syndrome: Complement activation, complement gene mutations, and therapeutic implications","volume":"19","author":"Chaturvedi","year":"2021","journal-title":"Journal of Thrombosis and Haemostasis"},{"issue":"7132","key":"10.1016\/j.imbio.2023.152413_b0160","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/nature05559","article-title":"C5L2 is critical for the biological activities of the anaphylatoxins C5a and C3a","volume":"446","author":"Chen","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.imbio.2023.152413_b0165","first-page":"252","article-title":"The C5a receptor of neutrophils and macrophages","volume":"12","author":"Chenoweth","year":"1983","journal-title":"Agents and Actions Supplements"},{"issue":"8","key":"10.1016\/j.imbio.2023.152413_b0170","doi-asserted-by":"crossref","first-page":"3943","DOI":"10.1073\/pnas.75.8.3943","article-title":"Demonstration of specific C5a receptor on intact human polymorphonuclear leukocytes","volume":"75","author":"Chenoweth","year":"1978","journal-title":"Proceedings of the National Academy of Sciences"},{"issue":"1","key":"10.1016\/j.imbio.2023.152413_b0175","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1002\/path.2157","article-title":"NADPH oxidase is required for neutrophil-dependent autoantibody-induced tissue damage","volume":"212","author":"Chiriac","year":"2007","journal-title":"The Journal of Pathology"},{"issue":"10","key":"10.1016\/j.imbio.2023.152413_b0180","doi-asserted-by":"crossref","first-page":"2530","DOI":"10.1111\/ajt.12405","article-title":"Immune cell-derived C3a and C5a costimulate human T Cell alloimmunity","volume":"13","author":"Cravedi","year":"2013","journal-title":"American Journal of Transplantation"},{"issue":"10","key":"10.1016\/j.imbio.2023.152413_b0185","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1038\/icb.2013.48","article-title":"C5a, but not C5a-des Arg, induces upregulation of heteromer formation between complement C5a receptors C5aR and C5L2","volume":"91","author":"Croker","year":"2013","journal-title":"Immunology and Cell Biology"},{"issue":"8","key":"10.1016\/j.imbio.2023.152413_b0190","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/icb.2016.43","article-title":"Discovery of functionally selective C5aR2 ligands: novel modulators of C5a signalling","volume":"94","author":"Croker","year":"2016","journal-title":"Immunology and Cell Biology"},{"issue":"8","key":"10.1016\/j.imbio.2023.152413_b0195","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/icb.2016.43","article-title":"Discovery of functionally selective C5aR2 ligands: novel modulators of C5a signalling","volume":"94","author":"Croker","year":"2016","journal-title":"Immunology and Cell Biology"},{"issue":"6","key":"10.1016\/j.imbio.2023.152413_b0200","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1038\/s41590-021-00926-0","article-title":"Dynamic regulation of B cell complement signaling is integral to germinal center responses","volume":"22","author":"Cumpelik","year":"2021","journal-title":"Nature Immunology"},{"issue":"3","key":"10.1016\/j.imbio.2023.152413_b0205","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.jaut.2008.04.017","article-title":"Role of Th1 and Th17 cells in organ-specific autoimmunity","volume":"31","author":"Dardalhon","year":"2008","journal-title":"Journal of Autoimmunity"},{"issue":"5","key":"10.1016\/j.imbio.2023.152413_b0210","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.cmrp.2019.07.013","article-title":"The membrane complement regulatory protein CD59 and its association with rheumatoid arthritis and systemic lupus erythematosus","volume":"9","author":"Das","year":"2019","journal-title":"Current Med. Res. Pract."},{"issue":"5","key":"10.1016\/j.imbio.2023.152413_b0215","first-page":"455","article-title":"Antiphospholipid antibodies and complement activation in patients with cerebral ischemia","volume":"10","author":"Davis","year":"1992","journal-title":"Clinical and Experimental Rheumatology"},{"issue":"16","key":"10.1016\/j.imbio.2023.152413_b0220","doi-asserted-by":"crossref","first-page":"4057","DOI":"10.1016\/j.molimm.2008.06.028","article-title":"Biological activities of C1 inhibitor","volume":"45","author":"Davis","year":"2008","journal-title":"Molecular Immunology"},{"issue":"1","key":"10.1016\/j.imbio.2023.152413_b0225","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1146\/annurev.physiol.69.022405.154749","article-title":"\u03b2-Arrestins and cell signaling","volume":"69","author":"DeWire","year":"2007","journal-title":"Annual Review of Physiology"},{"issue":"3","key":"10.1016\/j.imbio.2023.152413_b0230","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.kint.2017.09.018","article-title":"C5a receptor 1 promotes autoimmunity, neutrophil dysfunction and injury in experimental anti-myeloperoxidase glomerulonephritis","volume":"93","author":"Dick","year":"2018","journal-title":"Kidney International"},{"issue":"7","key":"10.1016\/j.imbio.2023.152413_b0235","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/j.intimp.2006.02.006","article-title":"C5a mediates secretion and activation of matrix metalloproteinase 9 from human eosinophils and neutrophils","volume":"6","author":"DiScipio","year":"2006","journal-title":"International Immunopharmacology"},{"issue":"3","key":"10.1016\/j.imbio.2023.152413_b0240","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.4049\/jimmunol.166.3.2025","article-title":"Expression of the complement anaphylatoxin C3a and C5a receptors on bronchial epithelial and smooth muscle cells in models of sepsis and asthma","volume":"166","author":"Drouin","year":"2001","journal-title":"The Journal of Immunology"},{"issue":"8","key":"10.1016\/j.imbio.2023.152413_b0245","doi-asserted-by":"crossref","first-page":"4032","DOI":"10.4049\/jimmunol.1103141","article-title":"C5aR expression in a Novel GFP reporter gene knockin mouse: implications for the mechanism of action of C5aR signaling in T cell immunity","volume":"188","author":"Dunkelberger","year":"2012","journal-title":"The Journal of Immunology"},{"issue":"3","key":"10.1016\/j.imbio.2023.152413_b0250","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1111\/j.1469-7793.1998.679bs.x","article-title":"A neuronal C5a receptor and an associated apoptotic signal transduction pathway","volume":"507","author":"Farkas","year":"1998","journal-title":"The Journal of Physiology"},{"issue":"1","key":"10.1016\/j.imbio.2023.152413_b0255","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1046\/j.1365-2567.2000.00911.x","article-title":"The C5a receptor is expressed in normal renal proximal tubular but not in normal pulmonary or hepatic epithelial cells","volume":"99","author":"Fayyazi","year":"2000","journal-title":"Immunology"},{"issue":"4","key":"10.1016\/j.imbio.2023.152413_b0260","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1038\/s41422-023-00779-2","article-title":"Mechanism of activation and biased signaling in complement receptor C5aR1","volume":"33","author":"Feng","year":"2023","journal-title":"Cell Research"},{"issue":"3","key":"10.1016\/j.imbio.2023.152413_b0265","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/BF02918259","article-title":"Complement deficiency states and meningococcal disease","volume":"12","author":"Figueroa","year":"1993","journal-title":"Immunologic Research"},{"issue":"11","key":"10.1016\/j.imbio.2023.152413_b0270","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1021\/jm9806594","article-title":"Low-molecular-weight peptidic and cyclic antagonists of the receptor for the complement factor C5a","volume":"42","author":"Finch","year":"1999","journal-title":"Journal of Medicinal Chemistry"},{"issue":"2","key":"10.1016\/j.imbio.2023.152413_b0275","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.4049\/jimmunol.0901005","article-title":"Treatment with a C5aR antagonist decreases pathology and enhances behavioral performance in murine models of alzheimer\u2019s disease","volume":"183","author":"Fonseca","year":"2009","journal-title":"The Journal of Immunology"},{"issue":"3","key":"10.1016\/j.imbio.2023.152413_b0280","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1677\/JOE-08-0110","article-title":"Complement C5a receptors in the pituitary gland: Expression and function","volume":"199","author":"Francis","year":"2008","journal-title":"The Journal of Endocrinology"},{"issue":"7","key":"10.1016\/j.imbio.2023.152413_b0285","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1038\/ni.1625","article-title":"Structure of and influence of a tick complement inhibitor on human complement component 5","volume":"9","author":"Fredslund","year":"2008","journal-title":"Nature Immunology"},{"issue":"11","key":"10.1016\/j.imbio.2023.152413_b8888","doi-asserted-by":"crossref","first-page":"5805","DOI":"10.4049\/jimmunol.1100338","article-title":"C5a Regulates NKT and NK Cell Functions in Sepsis","volume":"187","author":"Fusakio","year":"2011","journal-title":"Journal of Immunology"},{"issue":"6","key":"10.1016\/j.imbio.2023.152413_b0290","doi-asserted-by":"crossref","first-page":"3152","DOI":"10.4049\/jimmunol.155.6.3152","article-title":"Differential expression of complement receptors on human basophils and mast cells. Evidence for mast cell heterogeneity and CD88\/C5aR expression on skin mast cells","volume":"155","author":"F\u00fcreder","year":"1995","journal-title":"Journal of Immunology"},{"key":"10.1016\/j.imbio.2023.152413_b0295","doi-asserted-by":"crossref","first-page":"92","DOI":"10.3389\/fimmu.2011.00092","article-title":"The human C1q globular domain: structure and recognition of non-immune self ligands","volume":"2","author":"Gaboriaud","year":"2012","journal-title":"Frontiers in Immunology"},{"issue":"1","key":"10.1016\/j.imbio.2023.152413_b0300","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s12886-023-02774-y","article-title":"Identification of immune associated potential molecular targets in proliferative diabetic retinopathy","volume":"23","author":"Gao","year":"2023","journal-title":"BMC Ophthalmology"},{"key":"10.1016\/j.imbio.2023.152413_b0305","first-page":"368","article-title":"New insights for C5a and C5a receptors in sepsis","volume":"3","author":"Gao","year":"2012","journal-title":"Frontiers in Immunology"},{"issue":"20","key":"10.1016\/j.imbio.2023.152413_b0310","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13205134","article-title":"Overcoming resistance to immunotherapy in advanced cutaneous squamous cell carcinoma","volume":"13","author":"Garc\u00eda-Sancha","year":"2021","journal-title":"Cancers"},{"issue":"1","key":"10.1016\/j.imbio.2023.152413_b0315","first-page":"31","article-title":"Expression of the receptor for complement C5a (CD88) is up-regulated on reactive astrocytes, microglia, and endothelial cells in the inflamed human central nervous system","volume":"150","author":"Gasque","year":"1997","journal-title":"The American Journal of Pathology"},{"issue":"5","key":"10.1016\/j.imbio.2023.152413_b0320","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1111\/j.1471-4159.2004.02942.x","article-title":"Identification of complement 5a-like receptor (C5L2) from astrocytes: characterization of anti-inflammatory properties","volume":"92","author":"Gavrilyuk","year":"2005","journal-title":"Journal of Neurochemistry"},{"issue":"8","key":"10.1016\/j.imbio.2023.152413_b0325","doi-asserted-by":"crossref","first-page":"2600","DOI":"10.4049\/jimmunol.149.8.2600","article-title":"Structural diversity in the extracellular faces of peptidergic G-protein-coupled receptors. Molecular cloning of the mouse C5a anaphylatoxin receptor","volume":"149","author":"Gerard","year":"1992","journal-title":"Journal of Immunology"},{"issue":"6310","key":"10.1016\/j.imbio.2023.152413_b0330","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1038\/349614a0","article-title":"The chemotactic receptor for human C5a anaphylatoxin","volume":"349","author":"Gerard","year":"1991","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.imbio.2023.152413_b0335","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1016\/S0021-9258(18)94252-3","article-title":"Characterization of a receptor for C5a anaphylatoxin on human eosinophils","volume":"264","author":"Gerard","year":"1989","journal-title":"Journal of Biological Chemistry"},{"issue":"1","key":"10.1016\/j.imbio.2023.152413_b0340","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1111\/bjd.18877","article-title":"Clinical efficacy of complement C5a inhibition by IFX\u20101 in hidradenitis suppurativa: an open\u2010label single\u2010arm trial in patients not eligible for adalimumab","volume":"183","author":"Giamarellos\u2010Bourboulis","year":"2020","journal-title":"The British Journal of Dermatology"},{"issue":"4","key":"10.1016\/j.imbio.2023.152413_b0345","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines9040399","article-title":"Emerging role of C5 complement pathway in peripheral neuropathies: current treatments and future perspectives","volume":"9","author":"Giorgio","year":"2021","journal-title":"Biomedicines"},{"issue":"11","key":"10.1016\/j.imbio.2023.152413_b0350","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1172\/JCI200318817","article-title":"Complement C5a receptors and neutrophils mediate fetal injury in the antiphospholipid syndrome","volume":"112","author":"Girardi","year":"2003","journal-title":"Journal of Clinical Investigation"},{"key":"10.1016\/j.imbio.2023.152413_b0355","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1084\/jem.20020205","article-title":"Essential role for the C5a receptor in regulating the effector phase of synovial infiltration and joint destruction in experimental arthritis","volume":"196","author":"Grant","year":"2002","journal-title":"The Journal of Experimental Medicine"},{"key":"10.1016\/j.imbio.2023.152413_b0360","doi-asserted-by":"crossref","unstructured":"Gromova, M., Vaggelas, A., Dallmann, G., & Seimetz, D. (2020). Biomarkers: opportunities and challenges for drug development in the current regulatory landscape. Biomarker Insights, 15, 1177271920974652. https:\/\/doi.org\/10.1177\/1177271920974652.","DOI":"10.1177\/1177271920974652"},{"issue":"1","key":"10.1016\/j.imbio.2023.152413_b0365","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1146\/annurev.immunol.23.021704.115835","article-title":"Role of C5A in inflammatory responses","volume":"23","author":"Guo","year":"2004","journal-title":"Annual Review of Immunology"},{"issue":"3","key":"10.1016\/j.imbio.2023.152413_b0370","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1111\/j.1365-2567.2011.03445.x","article-title":"\u03b3\u03b4T-cell function in sepsis is modulated by C5a receptor signalling","volume":"133","author":"Han","year":"2011","journal-title":"Immunology"},{"issue":"6","key":"10.1016\/j.imbio.2023.152413_b0375","doi-asserted-by":"crossref","first-page":"e66305","DOI":"10.1371\/journal.pone.0066305","article-title":"A pro-inflammatory role of C5L2 in C5a-primed neutrophils for ANCA-induced activation","volume":"8","author":"Hao","year":"2013","journal-title":"PLoS One1"},{"key":"10.1016\/j.imbio.2023.152413_b0380","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.molimm.2017.05.015","article-title":"New concepts on the therapeutic control of complement anaphylatoxin receptors","volume":"89","author":"Hawksworth","year":"2017","journal-title":"Molecular Immunology"},{"issue":"5","key":"10.1016\/j.imbio.2023.152413_b0385","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/S0006-2952(00)00361-0","article-title":"Inhibition of C5a-induced neutrophil chemotaxis and macrophage cytokine production in vitro by a new C5a receptor antagonist","volume":"60","author":"Haynes","year":"2000","journal-title":"Biochemical Pharmacology"},{"issue":"6","key":"10.1016\/j.imbio.2023.152413_b0390","doi-asserted-by":"crossref","first-page":"4099","DOI":"10.4049\/jimmunol.166.6.4099","article-title":"Differential roles of the NPXXY motif in formyl peptide receptor signaling","volume":"166","author":"He","year":"2001","journal-title":"The Journal of Immunology"},{"issue":"5","key":"10.1016\/j.imbio.2023.152413_b0395","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1093\/rheumatology\/keh112","article-title":"Expression of Fc\u03b3 and complement receptors on peripheral blood monocytes in systemic lupus erythematosus and rheumatoid arthritis","volume":"43","author":"Hepburn","year":"2004","journal-title":"Rheumatology"},{"issue":"1","key":"10.1016\/j.imbio.2023.152413_b0400","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/s13024-017-0210-z","article-title":"Prevention of C5aR1 signaling delays microglial inflammatory polarization, favors clearance pathways and suppresses cognitive loss","volume":"12","author":"Hernandez","year":"2017","journal-title":"Molecular Neurodegeneration"},{"issue":"18","key":"10.1016\/j.imbio.2023.152413_b0405","doi-asserted-by":"crossref","first-page":"17831","DOI":"10.1074\/jbc.M410797200","article-title":"Comparative agonist\/antagonist responses in mutant human C5a receptors define the ligand binding site","volume":"280","author":"Higginbottom","year":"2005","journal-title":"The Journal of Biological Chemistry"},{"issue":"8","key":"10.1016\/j.imbio.2023.152413_b0410","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1038\/ng1599","article-title":"Complement factor 5 is a quantitative trait gene that modifies liver fibrogenesis in mice and humans","volume":"37","author":"Hillebrandt","year":"2005","journal-title":"Nature Genetics"},{"issue":"11","key":"10.1016\/j.imbio.2023.152413_b0415","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1056\/NEJMoa2029073","article-title":"Pegcetacoplan versus Eculizumab in Paroxysmal Nocturnal Hemoglobinuria","volume":"384","author":"Hillmen","year":"2021","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/j.imbio.2023.152413_b0420","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2019.01454","article-title":"Proteases in pemphigoid diseases","volume":"10","author":"Hiroyasu","year":"2019","journal-title":"Frontiers in Immunology"},{"issue":"12","key":"10.1016\/j.imbio.2023.152413_b0425","doi-asserted-by":"crossref","first-page":"2236","DOI":"10.1038\/mt.2013.178","article-title":"A novel C5a-neutralizing mirror-image (L-)aptamer prevents organ failure and improves survival in experimental sepsis","volume":"21","author":"Hoehlig","year":"2013","journal-title":"Molecular Therapy : The Journal of the American Society of Gene Therapy"},{"issue":"1","key":"10.1016\/j.imbio.2023.152413_b0430","first-page":"24","article-title":"Terminal complement pathway activation and low lysis inhibitors in rheumatoid arthritis synovial fluid","volume":"22","author":"H\u00f8g\u00e5sen","year":"1995","journal-title":"The Journal of Rheumatology"},{"key":"10.1016\/j.imbio.2023.152413_b0435","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2018.01057","article-title":"Complement in the initiation and evolution of rheumatoid arthritis","volume":"9","author":"Holers","year":"2018","journal-title":"Frontiers in Immunology"},{"issue":"2","key":"10.1016\/j.imbio.2023.152413_b0440","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1084\/jem.200116116","article-title":"Complement C3 activation is required for antiphospholipid antibody-induced fetal loss","volume":"195","author":"Holers","year":"2002","journal-title":"The Journal of Experimental Medicine"},{"issue":"12","key":"10.1016\/j.imbio.2023.152413_b0445","doi-asserted-by":"crossref","first-page":"e0189017","DOI":"10.1371\/journal.pone.0189017","article-title":"C5a and C5aR are elevated in joints of rheumatoid and psoriatic arthritis patients, and C5aR blockade attenuates leukocyte migration to synovial fluid","volume":"12","author":"Hornum","year":"2017","journal-title":"PLoS One1"},{"issue":"12","key":"10.1016\/j.imbio.2023.152413_b0450","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/S1474-4422(17)30369-1","article-title":"Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study","volume":"16","author":"Howard","year":"2017","journal-title":"The Lancet. Neurology"},{"issue":"7","key":"10.1016\/j.imbio.2023.152413_b0455","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1016\/j.cellsig.2014.02.021","article-title":"C5L2 is required for C5a-triggered receptor internalization and ERK signaling","volume":"26","author":"Hsu","year":"2014","journal-title":"Cellular Signalling"},{"issue":"9","key":"10.1016\/j.imbio.2023.152413_b0460","doi-asserted-by":"crossref","first-page":"2594","DOI":"10.1002\/jcb.23186","article-title":"Complement C3a and C5a modulate osteoclast formation and inflammatory response of osteoblasts in synergism with IL-1\u03b2","volume":"112","author":"Ignatius","year":"2011","journal-title":"Journal of Cellular Biochemistry"},{"issue":"2","key":"10.1016\/j.imbio.2023.152413_b0465","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.molimm.2014.06.039","article-title":"Complement and blood\u2013brain barrier integrity","volume":"61","author":"Jacob","year":"2014","journal-title":"Molecular Immunology"},{"issue":"6","key":"10.1016\/j.imbio.2023.152413_b0470","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1096\/fj.09-138834","article-title":"C5a alters blood-brain barrier integrity in experimental lupus","volume":"24","author":"Jacob","year":"2010","journal-title":"The FASEB Journal"},{"issue":"1","key":"10.1016\/j.imbio.2023.152413_b0475","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.jneuroim.2010.02.011","article-title":"Inhibition of C5a receptor alleviates experimental CNS lupus","volume":"221","author":"Jacob","year":"2010","journal-title":"Journal of Neuroimmunology"},{"issue":"5","key":"10.1016\/j.imbio.2023.152413_b0480","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1111\/j.1471-4159.2011.07490.x","article-title":"C5a\/CD88 signaling alters blood\u2013brain barrier integrity in lupus through nuclear factor-\u03baB","volume":"119","author":"Jacob","year":"2011","journal-title":"Journal of Neurochemistry"},{"issue":"2","key":"10.1016\/j.imbio.2023.152413_b0485","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1111\/j.1476-5381.2012.02183.x","article-title":"The C5a receptor antagonist PMX205 ameliorates experimentally induced colitis associated with increased IL-4 and IL-10","volume":"168","author":"Jain","year":"2013","journal-title":"British Journal of Pharmacology"},{"issue":"9","key":"10.1016\/j.imbio.2023.152413_b0490","doi-asserted-by":"crossref","first-page":"2756","DOI":"10.1681\/ASN.2016111179","article-title":"Randomized trial of C5a receptor inhibitor Avacopan in ANCA-associated vasculitis","volume":"28","author":"Jayne","year":"2017","journal-title":"Journal of the American Society of Nephrology: JASN"},{"issue":"7","key":"10.1016\/j.imbio.2023.152413_b0495","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1056\/NEJMoa2023386","article-title":"Avacopan for the Treatment of ANCA-Associated Vasculitis","volume":"384","author":"Jayne","year":"2021","journal-title":"The New England Journal of Medicine"},{"issue":"9","key":"10.1016\/j.imbio.2023.152413_b0500","doi-asserted-by":"crossref","first-page":"e0161867","DOI":"10.1371\/journal.pone.0161867","article-title":"C5a induces the synthesis of IL-6 and TNF-\u03b1 in rat glomerular mesangial cells through MAPK signaling pathways","volume":"11","author":"Ji","year":"2016","journal-title":"PLoS One1"},{"issue":"2","key":"10.1016\/j.imbio.2023.152413_b0505","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S1074-7613(02)00275-3","article-title":"Arthritis critically dependent on innate immune system players","volume":"16","author":"Ji","year":"2002","journal-title":"Immunity"},{"issue":"25","key":"10.1016\/j.imbio.2023.152413_b0510","doi-asserted-by":"crossref","first-page":"14598","DOI":"10.1073\/pnas.93.25.14598","article-title":"Phospholipase C \u03b24 is involved in modulating the visual response in mice","volume":"93","author":"Jiang","year":"1996","journal-title":"Proceedings of the National Academy of Sciences"},{"issue":"51","key":"10.1016\/j.imbio.2023.152413_b0515","doi-asserted-by":"crossref","first-page":"39088","DOI":"10.1074\/jbc.M609734200","article-title":"Ligand specificity of the anaphylatoxin C5L2 receptor and its regulation on myeloid and epithelial cell lines","volume":"281","author":"Johswich","year":"2006","journal-title":"The Journal of Biological Chemistry"},{"issue":"10","key":"10.1016\/j.imbio.2023.152413_b0520","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1136\/ard.49.10.747","article-title":"Measurement of the chemotactic complement fragment C5a in rheumatoid synovial fluids by radioimmunoassay: role of C5a in the acute inflammatory phase","volume":"49","author":"Jose","year":"1990","journal-title":"Annals of the Rheumatic Diseases"},{"issue":"7873","key":"10.1016\/j.imbio.2023.152413_b0525","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/s41586-021-03819-2","article-title":"Highly accurate protein structure prediction with AlphaFold","volume":"596","author":"Jumper","year":"2021","journal-title":"Nature"},{"issue":"13","key":"10.1016\/j.imbio.2023.152413_b0530","doi-asserted-by":"crossref","first-page":"11123","DOI":"10.1074\/jbc.M206169200","article-title":"The chemoattractant receptor-like protein C5L2 binds the C3a des-Arg77\/acylation-stimulating protein","volume":"278","author":"Kalant","year":"2003","journal-title":"The Journal of Biological Chemistry"},{"issue":"25","key":"10.1016\/j.imbio.2023.152413_b0535","doi-asserted-by":"crossref","first-page":"23936","DOI":"10.1074\/jbc.M406921200","article-title":"C5L2 is a functional receptor for acylation-stimulating protein","volume":"280","author":"Kalant","year":"2005","journal-title":"The Journal of Biological Chemistry"},{"issue":"11","key":"10.1016\/j.imbio.2023.152413_b0540","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/j.imbio.2012.07.015","article-title":"The immunoglobulin, IgG Fc receptor and complement triangle in autoimmune diseases","volume":"217","author":"Karsten","year":"2012","journal-title":"Immunobiology"},{"issue":"9","key":"10.1016\/j.imbio.2023.152413_b0545","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1038\/nm.2862","article-title":"Anti-inflammatory activity of IgG1 mediated by Fc galactosylation and association of Fc\u03b3RIIB and dectin-1","volume":"18","author":"Karsten","year":"2012","journal-title":"Nature Medicine"},{"issue":"4","key":"10.1016\/j.imbio.2023.152413_b0550","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.4049\/jimmunol.1401401","article-title":"Monitoring and cell-specific deletion of C5aR1 using a novel floxed GFP-C5aR1 reporter knock-in mouse","volume":"194","author":"Karsten","year":"2015","journal-title":"The Journal of Immunology"},{"issue":"9","key":"10.1016\/j.imbio.2023.152413_b0555","doi-asserted-by":"crossref","first-page":"3234","DOI":"10.4049\/jimmunol.1700710","article-title":"Monitoring C5aR2 expression using a floxed tdTomato-C5aR2 knock-in mouse","volume":"199","author":"Karsten","year":"2017","journal-title":"The Journal of Immunology"},{"issue":"8","key":"10.1016\/j.imbio.2023.152413_b0560","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1111\/j.1538-7836.2006.02046.x","article-title":"The complement component C5a induces the expression of plasminogen activator inhibitor-1 in human macrophages via NF-\u03baB activation","volume":"4","author":"Kastl","year":"2006","journal-title":"Journal of Thrombosis and Haemostasis"},{"key":"10.1016\/j.imbio.2023.152413_b0565","first-page":"717","article-title":"Targeting the Dark Horse of complement: The first generation of functionally selective C5aR2 ligands","volume":"Vol. 94","author":"Kemper","year":"2016"},{"issue":"3","key":"10.1016\/j.imbio.2023.152413_b0570","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.molimm.2013.05.223","article-title":"Novel roles for complement receptors in T cell regulation and beyond","volume":"56","author":"Kemper","year":"2013","journal-title":"Molecular Immunology"},{"issue":"15","key":"10.1016\/j.imbio.2023.152413_b0575","doi-asserted-by":"crossref","first-page":"6061","DOI":"10.1073\/pnas.1217991110","article-title":"Targeting complement component 5a promotes vascular integrity and limits airway remodeling","volume":"110","author":"Khan","year":"2013","journal-title":"Proceedings of the National Academy of Sciences"},{"issue":"5","key":"10.1016\/j.imbio.2023.152413_b0580","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1080\/15548627.2019.1580515","article-title":"Intracellular cytosolic complement component C3 regulates cytoprotective autophagy in pancreatic beta cells by interaction with ATG16L1","volume":"15","author":"King","year":"2019","journal-title":"Autophagy"},{"issue":"10","key":"10.1016\/j.imbio.2023.152413_b0585","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.it.2004.08.006","article-title":"C1q and tumor necrosis factor superfamily: modularity and versatility","volume":"25","author":"Kishore","year":"2004","journal-title":"Trends in Immunology"},{"issue":"14","key":"10.1016\/j.imbio.2023.152413_b0590","doi-asserted-by":"crossref","first-page":"2753","DOI":"10.1016\/j.molimm.2009.04.027","article-title":"The role of the anaphylatoxins in health and disease","volume":"46","author":"Klos","year":"2009","journal-title":"Molecular Immunology"},{"issue":"1","key":"10.1016\/j.imbio.2023.152413_b0595","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1124\/pr.111.005223","article-title":"International Union of Basic and Clinical Pharmacology. LXXXVII. Complement Peptide C5a, C4a, and C3a Receptors","volume":"65","author":"Klos","year":"2013","journal-title":"Pharmacological Reviews"},{"key":"10.1016\/j.imbio.2023.152413_b0600","doi-asserted-by":"crossref","first-page":"362","DOI":"10.3389\/fmed.2018.00362","article-title":"Epidermolysis bullosa acquisita: the 2019 update","volume":"5","author":"Koga","year":"2019","journal-title":"Frontiers in Medicine"},{"issue":"6","key":"10.1016\/j.imbio.2023.152413_b0605","first-page":"529","article-title":"Drug evaluation: the C5a receptor antagonist PMX-53","volume":"8","author":"K\u00f6hl","year":"2006","journal-title":"Current Opinion in Molecular Therapeutics"},{"issue":"3","key":"10.1016\/j.imbio.2023.152413_b0610","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.immuni.2020.02.006","article-title":"Diapedesis-induced integrin signaling via LFA-1 facilitates tissue immunity by inducing intrinsic complement C3 expression in immune cells","volume":"52","author":"Kolev","year":"2020","journal-title":"Immunity"},{"issue":"7","key":"10.1016\/j.imbio.2023.152413_b0615","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1182\/blood-2017-05-781450","article-title":"Eculizumab treatment and impaired opsonophagocytic killing of meningococci by whole blood from immunized adults","volume":"130","author":"Konar","year":"2017","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.imbio.2023.152413_b0620","doi-asserted-by":"crossref","first-page":"4200","DOI":"10.4049\/jimmunol.153.9.4200","article-title":"Development of C5a receptor antagonists. Differential loss of functional responses","volume":"153","author":"Konteatis","year":"1994","journal-title":"The Journal of Immunology"},{"issue":"6","key":"10.1016\/j.imbio.2023.152413_b0625","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1182\/blood-2018-09-876805","article-title":"Ravulizumab (ALXN1210) vs eculizumab in C5-inhibitor-experienced adult patients with PNH: The 302 study","volume":"133","author":"Kulasekararaj","year":"2019","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.imbio.2023.152413_b0630","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1182\/blood-2018-09-876805","article-title":"Ravulizumab (ALXN1210) vs eculizumab in C5-inhibitor\u2013experienced adult patients with PNH: the 302 study","volume":"133","author":"Kulasekararaj","year":"2019","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.imbio.2023.152413_b0635","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1016\/j.jaci.2015.10.018","article-title":"IL-10 mediates plasmacytosis-associated immunodeficiency by inhibiting complement-mediated neutrophil migration","volume":"137","author":"Kulkarni","year":"2016","journal-title":"The Journal of Allergy and Clinical Immunology"},{"issue":"5","key":"10.1016\/j.imbio.2023.152413_b0640","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1021\/acsomega.9b03735","article-title":"Preclinical pharmacokinetics of complement C5a receptor antagonists PMX53 and PMX205 in mice","volume":"5","author":"Kumar","year":"2020","journal-title":"ACS Omega"},{"issue":"1","key":"10.1016\/j.imbio.2023.152413_b0645","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/0165-5728(95)00075-D","article-title":"Expression of the receptors for the C5a anaphylatoxin, interleukin-8 and FMLP by human astrocytes and microglia","volume":"61","author":"Lacy","year":"1995","journal-title":"Journal of Neuroimmunology"},{"issue":"15","key":"10.1016\/j.imbio.2023.152413_b0650","doi-asserted-by":"crossref","first-page":"3615","DOI":"10.1182\/bloodadvances.2020002497","article-title":"Eculizumab impairs Neisseria meningitidis serogroup B killing in whole blood despite 4CMenB vaccination of PNH patients","volume":"4","author":"Langereis","year":"2020","journal-title":"Blood Advances"},{"issue":"9","key":"10.1016\/j.imbio.2023.152413_b0655","doi-asserted-by":"crossref","first-page":"3035","DOI":"10.1002\/(SICI)1521-4141(199909)29:09<3035::AID-IMMU3035>3.0.CO;2-Z","article-title":"Ligand-induced phosphorylation of anaphylatoxin receptors C3aR and C5aR is mediated by G protein-coupled receptor kinases","volume":"29","author":"Langkabel","year":"1999","journal-title":"European Journal of Immunology"},{"issue":"10","key":"10.1016\/j.imbio.2023.152413_b0660","first-page":"5962","article-title":"Expression and function of C5a receptor in mouse microvascular endothelial cells","volume":"169","author":"Laudes","year":"2002","journal-title":"Journal of Immunology (Baltimore, Md.\u202f: 1950)"},{"key":"10.1016\/j.imbio.2023.152413_b0665","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.molimm.2017.05.019","article-title":"Novel insights into the expression pattern of anaphylatoxin receptors in mice and men","volume":"89","author":"Laumonnier","year":"2017","journal-title":"Molecular Immunology"},{"issue":"1","key":"10.1016\/j.imbio.2023.152413_b0670","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0169-328X(00)00242-4","article-title":"Identification of four novel human G protein-coupled receptors expressed in the brain","volume":"86","author":"Lee","year":"2001","journal-title":"Molecular Brain Research"},{"issue":"8","key":"10.1016\/j.imbio.2023.152413_b0675","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1111\/bph.13730","article-title":"Pharmacological inhibition of complement C5a\u2013C5a1 receptor signalling ameliorates disease pathology in the hSOD1G93A mouse model of amyotrophic lateral sclerosis","volume":"174","author":"Lee","year":"2017","journal-title":"British Journal of Pharmacology"},{"issue":"6","key":"10.1016\/j.imbio.2023.152413_b0680","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1182\/blood-2018-09-876136","article-title":"Ravulizumab (ALXN1210) vs eculizumab in adult patients with PNH naive to complement inhibitors: the 301 study","volume":"133","author":"Lee","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.imbio.2023.152413_b0685","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20151437","article-title":"Myeloid cell transmigration across the CNS vasculature triggers IL-1\u03b2\u2013driven neuroinflammation during autoimmune encephalomyelitis in mice","volume":"213","author":"Levesque","year":"2016","journal-title":"The Journal of Experimental Medicine"},{"issue":"1","key":"10.1016\/j.imbio.2023.152413_b0690","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s13223-020-00437-x","article-title":"Co-occurrence between C1 esterase inhibitor deficiency and autoimmune disease: a systematic literature review","volume":"16","author":"Levy","year":"2020","journal-title":"Allergy, Asthma and Clinical Immunology"},{"issue":"1","key":"10.1016\/j.imbio.2023.152413_b0695","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s13223-020-0409-3","article-title":"Long-term efficacy and safety of subcutaneous C1-inhibitor in women with hereditary angioedema: subgroup analysis from an open-label extension of a phase 3 trial","volume":"16","author":"Levy","year":"2020","journal-title":"Allergy, Asthma and Clinical Immunology"},{"issue":"5","key":"10.1016\/j.imbio.2023.152413_b0700","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.metabol.2015.01.014","article-title":"C3a and C5a receptor antagonists ameliorate endothelial-myofibroblast transition via the Wnt\/\u03b2-catenin signaling pathway in diabetic kidney disease","volume":"64","author":"Li","year":"2015","journal-title":"Metabolism"},{"issue":"12","key":"10.1016\/j.imbio.2023.152413_b0705","doi-asserted-by":"crossref","first-page":"3339","DOI":"10.4049\/jimmunol.1900371","article-title":"The complement receptor C5aR2: A powerful modulator of innate and adaptive immunity","volume":"202","author":"Li","year":"2019","journal-title":"The Journal of Immunology"},{"key":"10.1016\/j.imbio.2023.152413_b0710","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2020.114156","article-title":"Pharmacological characterisation of small molecule C5aR1 inhibitors in human cells reveals biased activities for signalling and function","volume":"180","author":"Li","year":"2020","journal-title":"Biochemical Pharmacology"},{"issue":"2","key":"10.1016\/j.imbio.2023.152413_b0715","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.ophtha.2019.07.011","article-title":"Complement C3 inhibitor pegcetacoplan for geographic atrophy secondary to age-related macular degeneration: A randomized phase 2 trial","volume":"127","author":"Liao","year":"2020","journal-title":"Ophthalmology"},{"key":"10.1016\/j.imbio.2023.152413_b0720","doi-asserted-by":"crossref","first-page":"100722","DOI":"10.1016\/j.eclinm.2021.100722","article-title":"Complement inhibition in severe COVID-19 \u2013 Blocking C5a seems to be key","volume":"35","author":"Lim","year":"2021","journal-title":"EClinicalMedicine"},{"issue":"6","key":"10.1016\/j.imbio.2023.152413_b0725","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1016\/j.immuni.2013.10.018","article-title":"Intracellular complement activation sustains T cell homeostasis and mediates effector differentiation","volume":"39","author":"Liszewski","year":"2013","journal-title":"Immunity"},{"issue":"6","key":"10.1016\/j.imbio.2023.152413_b0730","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1038\/s41594-018-0067-z","article-title":"Orthosteric and allosteric action of the C5a receptor antagonists","volume":"25","author":"Liu","year":"2018","journal-title":"Nature Structural & Molecular Biology"},{"issue":"9","key":"10.1016\/j.imbio.2023.152413_b0735","doi-asserted-by":"crossref","first-page":"5882","DOI":"10.4049\/jimmunol.180.9.5882","article-title":"IFN-\u03b3 and IL-17 production in experimental autoimmune encephalomyelitis depends on local APC\u2013T cell complement production","volume":"180","author":"Liu","year":"2008","journal-title":"The Journal of Immunology"},{"key":"10.1016\/j.imbio.2023.152413_b0740","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2017.00245","article-title":"Optimum use of acute treatments for hereditary angioedema: evidence-based expert consensus","volume":"4","author":"Longhurst","year":"2018","journal-title":"Frontiers in Medicine"},{"issue":"1","key":"10.1016\/j.imbio.2023.152413_b0745","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1146\/annurev-immunol-032713-120225","article-title":"Immunology of Psoriasis","volume":"32","author":"Lowes","year":"2014","journal-title":"Annual Review of Immunology"},{"issue":"11","key":"10.1016\/j.imbio.2023.152413_b0750","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1080\/13543784.2020.1819981","article-title":"Pyoderma gangrenosum: proposed pathogenesis and current use of biologics with an emphasis on complement C5a inhibitor IFX-1","volume":"29","author":"Lu","year":"2020","journal-title":"Expert Opinion on Investigational Drugs"},{"issue":"2","key":"10.1016\/j.imbio.2023.152413_b0755","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s00281-008-0108-5","article-title":"New perspectives on effector mechanisms in uveitis","volume":"30","author":"Luger","year":"2008","journal-title":"Seminars in Immunopathology"},{"issue":"W1","key":"10.1016\/j.imbio.2023.152413_b0760","doi-asserted-by":"crossref","first-page":"W276","DOI":"10.1093\/nar\/gkac240","article-title":"Search and sequence analysis tools services from EMBL-EBI in 2022","volume":"50","author":"Madeira","year":"2022","journal-title":"Nucleic Acids Research"},{"issue":"14","key":"10.1016\/j.imbio.2023.152413_b0765","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2014492118","article-title":"CD11c+CD88+CD317+ myeloid cells are critical mediators of persistent CNS autoimmunity","volume":"118","author":"Manouchehri","year":"2021","journal-title":"Proceedings of the National Academy of Sciences"},{"issue":"5","key":"10.1016\/j.imbio.2023.152413_b0770","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1007\/s40257-022-00699-8","article-title":"Pyoderma gangrenosum: An updated literature review on established and emerging pharmacological treatments","volume":"23","author":"Maronese","year":"2022","journal-title":"American Journal of Clinical Dermatology"},{"issue":"4","key":"10.1016\/j.imbio.2023.152413_b0775","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1111\/eci.12419","article-title":"Compstatin: a C3-targeted complement inhibitor reaching its prime for bedside intervention","volume":"45","author":"Mastellos","year":"2015","journal-title":"European Journal of Clinical Investigation"},{"issue":"1","key":"10.1016\/j.imbio.2023.152413_b0780","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/omi.12129","article-title":"Complement therapeutics in inflammatory diseases: promising drug candidates for C3-targeted intervention","volume":"31","author":"Mastellos","year":"2016","journal-title":"Molecular Oral Microbiology"},{"issue":"9","key":"10.1016\/j.imbio.2023.152413_b0785","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1038\/s41573-019-0031-6","article-title":"Clinical promise of next-generation complement therapeutics","volume":"18","author":"Mastellos","year":"2019","journal-title":"Nature Reviews. Drug Discovery"},{"issue":"8","key":"10.1016\/j.imbio.2023.152413_b0790","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1001\/jama.2020.26858","article-title":"Diagnosis and treatment of multiple sclerosis: a review","volume":"325","author":"McGinley","year":"2021","journal-title":"Journal of the American Medical Association (JAMA)"},{"issue":"23","key":"10.1016\/j.imbio.2023.152413_b0795","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1056\/NEJMra1004965","article-title":"The pathogenesis of rheumatoid arthritis","volume":"365","author":"McInnes","year":"2011","journal-title":"The New England Journal of Medicine"},{"issue":"3","key":"10.1016\/j.imbio.2023.152413_b0800","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s40265-019-01068-2","article-title":"Ravulizumab: First global approval","volume":"79","author":"McKeage","year":"2019","journal-title":"Drugs"},{"issue":"27","key":"10.1016\/j.imbio.2023.152413_b0805","doi-asserted-by":"crossref","first-page":"734","DOI":"10.15585\/mmwr.mm6627e1","article-title":"High risk for invasive meningococcal disease among patients receiving eculizumab (soliris) despite receipt of meningococcal vaccine","volume":"66","author":"McNamara","year":"2017","journal-title":"MMWR. Morbidity and Mortality Weekly Report"},{"issue":"11","key":"10.1016\/j.imbio.2023.152413_b0810","doi-asserted-by":"crossref","first-page":"5446","DOI":"10.4049\/jimmunol.1403012","article-title":"A new approach for the treatment of arthritis in mice with a novel conjugate of an anti-C5aR1 antibody and C5 small interfering RNA","volume":"194","author":"Mehta","year":"2015","journal-title":"The Journal of Immunology"},{"key":"10.1016\/j.imbio.2023.152413_b0815","doi-asserted-by":"crossref","first-page":"262","DOI":"10.3389\/fimmu.2015.00262","article-title":"Complement System Part I - Molecular Mechanisms of Activation and Regulation","volume":"6","author":"Merle","year":"2015","journal-title":"Frontiers in Immunology"},{"issue":"3","key":"10.1016\/j.imbio.2023.152413_b0820","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1182\/blood-2015-09-672139","article-title":"Complement activation in antiphospholipid syndrome and its inhibition to prevent rethrombosis after arterial surgery","volume":"127","author":"Meroni","year":"2016","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.imbio.2023.152413_b0825","doi-asserted-by":"crossref","DOI":"10.1186\/s40478-018-0536-y","article-title":"Systemic inhibition of the membrane attack complex impedes neuroinflammation in chronic relapsing experimental autoimmune encephalomyelitis","volume":"6","author":"Michailidou","year":"2018","journal-title":"Acta Neuropathologica Communications"},{"key":"10.1016\/j.imbio.2023.152413_b0830","doi-asserted-by":"crossref","first-page":"535","DOI":"10.3389\/fimmu.2018.00535","article-title":"Specific inhibition of complement activation significantly ameliorates autoimmune blistering disease in mice","volume":"9","author":"Mihai","year":"2018","journal-title":"Frontiers in Immunology"},{"issue":"9","key":"10.1016\/j.imbio.2023.152413_b0835","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.imbio.2014.03.018","article-title":"Expression and regulation of complement receptors by human natural killer cells","volume":"219","author":"Min","year":"2014","journal-title":"Immunobiology"},{"issue":"6342","key":"10.1016\/j.imbio.2023.152413_b0840","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1126\/science.aaj2067","article-title":"Local amplifiers of IL-4R\u03b1\u2013mediated macrophage activation promote repair in lung and liver","volume":"356","author":"Minutti","year":"2017","journal-title":"Science"},{"issue":"7","key":"10.1016\/j.imbio.2023.152413_b0845","doi-asserted-by":"crossref","first-page":"eaaj2195","DOI":"10.1126\/sciimmunol.aaj2195","article-title":"Complement C5a receptor is the key initiator of neutrophil adhesion igniting immune complex\u2013induced arthritis","volume":"2","author":"Miyabe","year":"2017","journal-title":"Science Immunology"},{"issue":"35","key":"10.1016\/j.imbio.2023.152413_b0850","doi-asserted-by":"crossref","first-page":"eaav5951","DOI":"10.1126\/sciimmunol.aav5951","article-title":"Atypical complement receptor C5aR2 transports C5a to initiate neutrophil adhesion and inflammation","volume":"4","author":"Miyabe","year":"2019","journal-title":"Science Immunology"},{"issue":"1","key":"10.1016\/j.imbio.2023.152413_b0855","first-page":"1","article-title":"Adoptive transfer of experimental autoimmune uveoretinitis in rats. Immunopathogenic mechanisms and histologic features","volume":"26","author":"Mochizuki","year":"1985","journal-title":"Investigative Ophthalmology & Visual Science"},{"issue":"3","key":"10.1016\/j.imbio.2023.152413_b0860","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1042\/bj2950679","article-title":"Characterization of a complement-fragment-C5a-stimulated calcium-influx mechanism in U937 monocytic cells","volume":"295","author":"Monk","year":"1993","journal-title":"Biochemical Journal"},{"issue":"4","key":"10.1016\/j.imbio.2023.152413_b0865","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/sj.bjp.0707332","article-title":"Function, structure and therapeutic potential of complement C5a receptors","volume":"152","author":"Monk","year":"2007","journal-title":"British Journal of Pharmacology"},{"issue":"1","key":"10.1016\/j.imbio.2023.152413_b0870","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1046\/j.1365-2567.1996.d01-701.x","article-title":"Expression and modulation of C5a receptor (CD88) on skin dendritic cells. Chemotactic effect of C5a on skin migratory dendritic cells","volume":"89","author":"Morelli","year":"1996","journal-title":"Immunology"},{"issue":"3","key":"10.1016\/j.imbio.2023.152413_b0875","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1111\/j.1365-2249.2004.02646.x","article-title":"Blockade of the C5a receptor fails to protect against experimental autoimmune encephalomyelitis in rats","volume":"138","author":"Morgan","year":"2004","journal-title":"Clinical and Experimental Immunology"},{"issue":"47","key":"10.1016\/j.imbio.2023.152413_b0880","doi-asserted-by":"crossref","first-page":"16937","DOI":"10.1073\/pnas.1417365111","article-title":"Targeting the minor pocket of C5aR for the rational design of an oral allosteric inhibitor for inflammatory and neuropathic pain relief","volume":"111","author":"Moriconi","year":"2014","journal-title":"Proceedings of the National Academy of Sciences"},{"issue":"5","key":"10.1016\/j.imbio.2023.152413_b0885","first-page":"1901","article-title":"Complement C5a activation of phospholipase D in human neutrophils. A major route to the production of phosphatidates and diglycerides","volume":"144","author":"Mullmann","year":"1990","journal-title":"Journal of Immunology (Baltimore, Md.\u202f: 1950)"},{"issue":"1","key":"10.1016\/j.imbio.2023.152413_b0890","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1002\/mus.26447","article-title":"Long-term safety and efficacy of eculizumab in generalized myasthenia gravis","volume":"60","author":"Muppidi","year":"2019","journal-title":"Muscle & Nerve"},{"issue":"10","key":"10.1016\/j.imbio.2023.152413_b0895","doi-asserted-by":"crossref","first-page":"11060","DOI":"10.1096\/fj.201800980RR","article-title":"C5a receptors C5aR1 and C5aR2 mediate opposing pathologies in a mouse model of melanoma","volume":"33","author":"Nabizadeh","year":"2019","journal-title":"The FASEB Journal"},{"issue":"52","key":"10.1016\/j.imbio.2023.152413_b0900","doi-asserted-by":"crossref","first-page":"19737","DOI":"10.1073\/pnas.0609791104","article-title":"Structural transitions of complement component C3 and its activation products","volume":"103","author":"Nishida","year":"2006","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"66","key":"10.1016\/j.imbio.2023.152413_b0905","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abf2489","article-title":"Mitochondrial C5aR1 activity in macrophages controls IL-1\u03b2 production underlying sterile inflammation","volume":"6","author":"Niyonzima","year":"2021","journal-title":"Science Immunology"},{"issue":"8","key":"10.1016\/j.imbio.2023.152413_b0910","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1002\/glia.22680","article-title":"Fosb gene products contribute to excitotoxic microglial activation by regulating the expression of complement C5a receptors in microglia","volume":"62","author":"Nomaru","year":"2014","journal-title":"Glia"},{"issue":"8","key":"10.1016\/j.imbio.2023.152413_b0915","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S0161-5890(00)00067-5","article-title":"A putative chemoattractant receptor, C5L2, is expressed in granulocyte and immature dendritic cells, but not in mature dendritic cells","volume":"37","author":"Ohno","year":"2000","journal-title":"Molecular Immunology"},{"issue":"31","key":"10.1016\/j.imbio.2023.152413_b0920","doi-asserted-by":"crossref","first-page":"9406","DOI":"10.1021\/bi034489v","article-title":"C5L2, a nonsignaling C5A binding protein","volume":"42","author":"Okinaga","year":"2003","journal-title":"Biochemistry"},{"issue":"4","key":"10.1016\/j.imbio.2023.152413_b0925","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/S0306-4522(98)00372-8","article-title":"Expression of C5a receptor in mouse brain: role in signal transduction and neurodegeneration","volume":"88","author":"Osaka","year":"1999","journal-title":"Neuroscience"},{"issue":"11","key":"10.1016\/j.imbio.2023.152413_b0930","doi-asserted-by":"crossref","first-page":"6510","DOI":"10.4049\/jimmunol.162.11.6510","article-title":"rC5a directs the in vitro migration of human memory and naive tonsillar B lymphocytes: Implications for B Cell trafficking in secondary lymphoid tissues","volume":"162","author":"Ottonello","year":"1999","journal-title":"The Journal of Immunology"},{"issue":"2","key":"10.1016\/j.imbio.2023.152413_b0935","doi-asserted-by":"crossref","first-page":"379","DOI":"10.4049\/jimmunol.1900276","article-title":"Follicular B2 cell activation and class switch recombination depend on autocrine C3ar1\/C5ar1 signaling in B2 cells","volume":"203","author":"Paiano","year":"2019","journal-title":"The Journal of Immunology"},{"issue":"1","key":"10.1016\/j.imbio.2023.152413_b0940","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/S0167-4781(98)00198-5","article-title":"Anaphylatoxins C5a and C3a induce nuclear factor \u03baB activation in human peripheral blood monocytes","volume":"1443","author":"Pan","year":"1998","journal-title":"Biochim. et Biophys. Acta (BBA) - Gene Structure and Expression"},{"issue":"24","key":"10.1016\/j.imbio.2023.152413_b0945","doi-asserted-by":"crossref","first-page":"9416","DOI":"10.1074\/jbc.RA119.007485","article-title":"Partial ligand-receptor engagement yields functional bias at the human complement receptor, C5aR1","volume":"294","author":"Pandey","year":"2019","journal-title":"The Journal of Biological Chemistry"},{"issue":"22","key":"10.1016\/j.imbio.2023.152413_b0950","doi-asserted-by":"crossref","first-page":"4605","DOI":"10.1016\/j.molcel.2021.09.007","article-title":"Intrinsic bias at non-canonical, \u03b2-arrestin-coupled seven transmembrane receptors","volume":"81","author":"Pandey","year":"2021","journal-title":"Molecular Cell"},{"issue":"1","key":"10.1016\/j.imbio.2023.152413_b0955","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.kint.2019.01.039","article-title":"The C5a\/C5aR1 axis promotes progression of renal tubulointerstitial fibrosis in a mouse model of renal ischemia\/reperfusion injury","volume":"96","author":"Peng","year":"2019","journal-title":"Kidney International"},{"issue":"2","key":"10.1016\/j.imbio.2023.152413_b0960","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1046\/j.1523-1755.2002.00139.x","article-title":"C5a delays apoptosis of human neutrophils by a phosphatidylinositol 3-kinase-signaling pathway","volume":"61","author":"Perianayagam","year":"2002","journal-title":"Kidney International"},{"key":"10.1016\/j.imbio.2023.152413_b0965","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1111\/j.1365-2362.2006.01637.x","article-title":"CREB transcription factor modulates Bcl2 transcription in response to C5a in HL-60-derived neutrophils","volume":"36","author":"Perianayagam","year":"2006","journal-title":"European Journal of Clinical Investigation"},{"issue":"1","key":"10.1016\/j.imbio.2023.152413_b0970","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1146\/annurev.iy.04.040186.001311","article-title":"Molecular immunobiology of complement biosynthesis: a model of single-cell control of effector-inhibitor balance","volume":"4","author":"Perlmutter","year":"1986","journal-title":"Annual Review of Immunology"},{"issue":"7","key":"10.1016\/j.imbio.2023.152413_b0975","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1002\/art.21157","article-title":"Requirement of activation of complement C3 and C5 for antiphospholipid antibody\u2013mediated thrombophilia","volume":"52","author":"Pierangeli","year":"2005","journal-title":"Arthritis and Rheumatism"},{"issue":"9","key":"10.1016\/j.imbio.2023.152413_b0980","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1038\/nrm908","article-title":"Seven-transmembrane receptors","volume":"3","author":"Pierce","year":"2002","journal-title":"Nature Reviews. Molecular Cell Biology"},{"issue":"7","key":"10.1016\/j.imbio.2023.152413_b0985","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1056\/NEJMoa1900866","article-title":"Eculizumab in aquaporin-4\u2013positive neuromyelitis optica spectrum disorder","volume":"381","author":"Pittock","year":"2019","journal-title":"New England Journal of Medicine"},{"issue":"7","key":"10.1016\/j.imbio.2023.152413_b0995","doi-asserted-by":"crossref","first-page":"3193","DOI":"10.1096\/fj.201601218R","article-title":"Critical role for complement receptor C5aR2 in the pathogenesis of renal ischemia-reperfusion injury","volume":"31","author":"Poppelaars","year":"2017","journal-title":"The FASEB Journal"},{"issue":"4","key":"10.1016\/j.imbio.2023.152413_b1000","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1016\/j.cellsig.2012.12.010","article-title":"C5L2 and C5aR interaction in adipocytes and macrophages: insights into adipoimmunology","volume":"25","author":"Poursharifi","year":"2013","journal-title":"Cellular Signalling"},{"issue":"3","key":"10.1016\/j.imbio.2023.152413_b1005","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/art.41407","article-title":"New Therapeutic Targets in Antineutrophil Cytoplasm Antibody-Associated Vasculitis","volume":"73","author":"Prendecki","year":"2021","journal-title":"Arthri. Rheumatol. (Hoboken, N.J.)"},{"issue":"6","key":"10.1016\/j.imbio.2023.152413_b1010","doi-asserted-by":"crossref","first-page":"2774","DOI":"10.4049\/jimmunol.1401348","article-title":"The novel receptor C5aR2 is required for C5a-mediated human mast cell adhesion, migration, and proinflammatory mediator production","volume":"195","author":"Pundir","year":"2015","journal-title":"The Journal of Immunology"},{"issue":"2","key":"10.1016\/j.imbio.2023.152413_b1015","first-page":"688","article-title":"Monitoring C3aR expression using a floxed tdTomato-C3aR reporter knock-in mouse","volume":"199","author":"Quell","year":"2017","journal-title":"Journal of Immunology (Baltimore, Md.\u202f: 1950)"},{"issue":"7","key":"10.1016\/j.imbio.2023.152413_b1020","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1182\/blood-2007-01-070631","article-title":"Tissue factor: A link between C5a and neutrophil activation in antiphospholipid antibody-induced fetal injury","volume":"110","author":"Redecha","year":"2007","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.imbio.2023.152413_b1025","first-page":"3453","article-title":"Neutrophil activation by the tissue factor\/Factor VIIa\/PAR2 axis mediates fetal death in a mouse model of antiphospholipid syndrome","volume":"118","author":"Redecha","year":"2008","journal-title":"The Journal of Clinical Investigation"},{"issue":"4","key":"10.1016\/j.imbio.2023.152413_b1030","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1002\/1521-4141(200204)32:4<1157::AID-IMMU1157>3.0.CO;2-M","article-title":"Disruption of the C5a receptor gene fails to protect against experimental allergic encephalomyelitis","volume":"32","author":"Reiman","year":"2002","journal-title":"European Journal of Immunology"},{"issue":"4","key":"10.1016\/j.imbio.2023.152413_b1035","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/j.bbamem.2006.09.019","article-title":"The G protein-coupled receptor kinase (GRK) interactome: Role of GRKs in GPCR regulation and signaling","volume":"1768","author":"Ribas","year":"2007","journal-title":"Biochimica et Biophysica Acta (BBA) \u2013 Biomembranes"},{"issue":"9","key":"10.1016\/j.imbio.2023.152413_b1040","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1038\/ni.1923","article-title":"Complement: a key system for immune surveillance and homeostasis","volume":"11","author":"Ricklin","year":"2010","journal-title":"Nature Immunology"},{"key":"10.1016\/j.imbio.2023.152413_b1045","doi-asserted-by":"crossref","DOI":"10.1038\/s41573-019-0055-y","article-title":"Therapeutic targeting of the complement system","author":"Ricklin","year":"2019","journal-title":"Nature Reviews. Drug Discovery"},{"issue":"4","key":"10.1016\/j.imbio.2023.152413_b1050","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.4049\/jimmunol.168.4.1919","article-title":"Expression and function of the C5a receptor in rat alveolar epithelial cells","volume":"168","author":"Riedemann","year":"2002","journal-title":"The Journal of Immunology"},{"issue":"2","key":"10.1016\/j.imbio.2023.152413_b1055","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S1074-7613(03)00206-1","article-title":"Regulation by C5a of neutrophil activation during sepsis","volume":"19","author":"Riedemann","year":"2003","journal-title":"Immunity"},{"issue":"2","key":"10.1016\/j.imbio.2023.152413_b1060","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1096\/fj.03-0708fje","article-title":"Regulatory role of C5a in LPS-induced IL-6 production by neutrophils during sepsis","volume":"18","author":"Riedemann","year":"2004","journal-title":"The FASEB Journal"},{"issue":"7686","key":"10.1016\/j.imbio.2023.152413_b1065","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/nature25025","article-title":"Structure of the complement C5a receptor bound to the extra-helical antagonist NDT9513727","volume":"553","author":"Robertson","year":"2018","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.imbio.2023.152413_b1070","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s11481-006-9012-8","article-title":"Microglia as a pharmacological target in infectious and inflammatory diseases of the brain","volume":"1","author":"Rock","year":"2006","journal-title":"Journal of Neuroimmune Pharmacology"},{"issue":"4","key":"10.1016\/j.imbio.2023.152413_b1075","doi-asserted-by":"crossref","first-page":"2334","DOI":"10.1074\/jbc.M114.605691","article-title":"A revised mechanism for the activation of complement C3 to C3b: a molecular explanation of a disease-associated polymorphism","volume":"290","author":"Rodriguez","year":"2015","journal-title":"The Journal of Biological Chemistry"},{"issue":"1","key":"10.1016\/j.imbio.2023.152413_b1080","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1196\/annals.1422.058","article-title":"C5a receptor-deficient mice are protected from thrombophilia and endothelial cell activation induced by some antiphospholipid antibodies","volume":"1108","author":"Romay-penabad","year":"2007","journal-title":"Annals of the New York Academy of Sciences"},{"issue":"11","key":"10.1016\/j.imbio.2023.152413_b1085","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1038\/nbt1344","article-title":"Discovery and development of the complement inhibitor eculizumab for the treatment of paroxysmal nocturnal hemoglobinuria","volume":"25","author":"Rother","year":"2007","journal-title":"Nature Biotechnology"},{"issue":"11","key":"10.1016\/j.imbio.2023.152413_b1090","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1016\/j.cellsig.2006.02.006","article-title":"CXCL12 and C5a trigger cell migration via a PAK1\/2-p38\u03b1 MAPK-MAPKAP-K2-HSP27 pathway","volume":"18","author":"Rousseau","year":"2006","journal-title":"Cellular Signalling"},{"issue":"9","key":"10.1016\/j.imbio.2023.152413_b1095","doi-asserted-by":"crossref","first-page":"3762","DOI":"10.1096\/fj.15-271635","article-title":"Experimental design of complement component 5a-induced acute lung injury (C5a-ALI): a role of CC-chemokine receptor type 5 during immune activation by anaphylatoxin","volume":"29","author":"Russkamp","year":"2015","journal-title":"The FASEB Journal"},{"issue":"46","key":"10.1016\/j.imbio.2023.152413_b1100","article-title":"Neutrophils orchestrate their own recruitment in murine arthritis through C5aR and Fc\u03b3R signaling","volume":"109","author":"Sadik","year":"2012","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.imbio.2023.152413_b1105","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.smim.2018.03.002","article-title":"The critical role of C5a as an initiator of neutrophil-mediated autoimmune inflammation of the joint and skin","volume":"37","author":"Sadik","year":"2018","journal-title":"Seminars in Immunology"},{"key":"10.1016\/j.imbio.2023.152413_b1110","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.970486","article-title":"The role of the complement system in multiple sclerosis: a review","volume":"13","author":"Saez-Calveras","year":"2022","journal-title":"Frontiers in Immunology"},{"key":"10.1016\/j.imbio.2023.152413_b1115","doi-asserted-by":"crossref","unstructured":"Saha, S., Maharana, J., Yadav, M. K., Sarma, P., Singh, V., Mohapatra, S., Soni, C., Saha, S., Mishra, S., Ganguly, M., Chami, M., Banerjee, R., & Shukla, A. K. (2023). Structural insights into ligand-recognition, activation, and signaling-bias at the complement C5a receptor, C5aR1. BioRxiv, 2023.01.14.524051. https:\/\/doi.org\/10.1101\/2023.01.14.524051.","DOI":"10.1101\/2023.01.14.524051"},{"issue":"2","key":"10.1016\/j.imbio.2023.152413_b1120","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1080\/14397595.2016.1193965","article-title":"Differential activation mechanisms of serum C5a in lupus nephritis and neuropsychiatric systemic lupus erythematosus","volume":"27","author":"Sakuma","year":"2017","journal-title":"Modern Rheumatology"},{"key":"10.1016\/j.imbio.2023.152413_b1125","doi-asserted-by":"crossref","unstructured":"Sarma, J. V., & Ward, P. A. (2012). New developments in C5a receptor signaling. In Cell Health and Cytoskeleton (Vol. 4, pp. 73\u201382). https:\/\/doi.org\/10.2147\/CHC.S27233.","DOI":"10.2147\/CHC.S27233"},{"key":"10.1016\/j.imbio.2023.152413_b1130","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.958392","article-title":"Anaphylatoxins spark the flame in early autoimmunity","volume":"13","author":"Schanzenbacher","year":"2022","journal-title":"Frontiers in Immunology"},{"key":"10.1016\/j.imbio.2023.152413_b1135","first-page":"1287","article-title":"Differential expression of the C5a receptor on the main cell types of rat liver as demonstrated with a novel monoclonal antibody and by C5a anaphylatoxin-induced Ca2+ release.","volume":"79 10","author":"Schlaf","year":"1999","journal-title":"LaboratoryInvestigation; J. Techn. Method. Pathol."},{"issue":"9863","key":"10.1016\/j.imbio.2023.152413_b1140","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/S0140-6736(12)61140-4","article-title":"Pemphigoid diseases","volume":"381","author":"Schmidt","year":"2013","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.imbio.2023.152413_b1145","doi-asserted-by":"crossref","first-page":"3664","DOI":"10.1074\/jbc.M609178200","article-title":"The role of the N-terminal domain of the complement fragment receptor C5L2 in ligand binding","volume":"282","author":"Scola","year":"2007","journal-title":"The Journal of Biological Chemistry"},{"issue":"6","key":"10.1016\/j.imbio.2023.152413_b1150","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/j.molimm.2008.11.001","article-title":"The human complement fragment receptor, C5L2, is a recycling decoy receptor","volume":"46","author":"Scola","year":"2009","journal-title":"Molecular Immunology"},{"key":"10.1016\/j.imbio.2023.152413_b1155","article-title":"The importance of C5aR2 in neutrophil function and its impact on neutrophil-mediated diseases","volume":"194 4 (6)","author":"Seiler","year":"2022","journal-title":"Journal of Cellular Immunology"},{"key":"10.1016\/j.imbio.2023.152413_b1160","doi-asserted-by":"crossref","DOI":"10.1016\/j.jid.2021.12.029","article-title":"C5aR2 deficiency ameliorates inflammation in murine epidermolysis bullosa acquisita by regulating Fc\u03b3RIIb expression on neutrophils","author":"Seiler","year":"2022","journal-title":"Journal of Investigative Dermatology"},{"issue":"15","key":"10.1016\/j.imbio.2023.152413_b1165","doi-asserted-by":"crossref","first-page":"e128239","DOI":"10.1172\/jci.insight.128239","article-title":"Dual inhibition of complement factor 5 and leukotriene B4 synergistically suppresses murine pemphigoid disease","volume":"4","author":"Sezin","year":"2019","journal-title":"JCI Insight"},{"issue":"4","key":"10.1016\/j.imbio.2023.152413_b1170","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1080\/1744666X.2020.1745063","article-title":"Revisiting the complement system in systemic lupus erythematosus","volume":"16","author":"Sharma","year":"2020","journal-title":"Expert Review of Clinical Immunology"},{"issue":"3","key":"10.1016\/j.imbio.2023.152413_b1175","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1042\/bj2750809","article-title":"The regulation of actin polymerization in differentiating U937 cells correlates with increased membrane levels of the pertussis-toxin-sensitive G-protein Gi2","volume":"275","author":"Sheth","year":"1991","journal-title":"Biochemistry Journal"},{"issue":"6","key":"10.1016\/j.imbio.2023.152413_b1180","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1134\/S1019331622060041","article-title":"Scientific basics of personalized medicine: realities and opportunities","volume":"92","author":"Shlyakhto","year":"2022","journal-title":"Herald of the Russian Academy of Sciences"},{"issue":"5","key":"10.1016\/j.imbio.2023.152413_b1185","doi-asserted-by":"crossref","first-page":"3041","DOI":"10.4049\/jimmunol.174.5.3041","article-title":"Macrophages induce the inflammatory response in the pulmonary arthus reaction through G\u03b1i2 activation that controls C5aR and Fc receptor cooperation","volume":"174","author":"Skokowa","year":"2005","journal-title":"The Journal of Immunology"},{"issue":"1","key":"10.1016\/j.imbio.2023.152413_b1190","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1186\/s13063-020-04548-z","volume":"21","author":"Smith","year":"2020","journal-title":"Trials"},{"issue":"1","key":"10.1016\/j.imbio.2023.152413_b8881","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0165-2478(03)00052-X","article-title":"Characterization of C5aR expression on murine myeloid and lymphoid cells by the use of a novel monoclonal antibody","volume":"88","author":"Soruri","year":"2003","journal-title":"Immunology Letters"},{"issue":"3","key":"10.1016\/j.imbio.2023.152413_b1195","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.immuni.2008.02.001","article-title":"Locally produced complement fragments C5a and C3a provide both costimulatory and survival signals to naive CD4+ T cells","volume":"28","author":"Strainic","year":"2008","journal-title":"Immunity"},{"issue":"4","key":"10.1016\/j.imbio.2023.152413_b1200","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1093\/cid\/ciu887","article-title":"Treatment with anti-C5a antibody improves the outcome of H7N9 virus infection in african green monkeys","volume":"60","author":"Sun","year":"2015","journal-title":"Clinical Infectious Diseases"},{"issue":"17","key":"10.1016\/j.imbio.2023.152413_b1205","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23179716","article-title":"Immunomodulatory drugs in the treatment of hidradenitis suppurativa \u2013possibilities and limitations","volume":"23","author":"\u015awierczewska","year":"2022","journal-title":"International Journal of Molecular Sciences"},{"issue":"1","key":"10.1016\/j.imbio.2023.152413_b1210","doi-asserted-by":"crossref","first-page":"83","DOI":"10.2337\/db19-0043","article-title":"Complement C5a induces renal injury in diabetic kidney disease by disrupting mitochondrial metabolic agility","volume":"69","author":"Tan","year":"2019","journal-title":"Diabetes"},{"issue":"2","key":"10.1016\/j.imbio.2023.152413_b1215","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1042\/bj20021803","article-title":"Direct binding of a fragment of the Wiskott-Aldrich syndrome protein to the C-terminal end of the anaphylatoxin C5a receptor","volume":"372","author":"Tardif","year":"2003","journal-title":"Biochemical Journal"},{"issue":"4\u20135","key":"10.1016\/j.imbio.2023.152413_b1220","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1078\/0171-2985-00155","article-title":"Interaction of C1q and mannan-binding lectin with viruses","volume":"205","author":"Thielens","year":"2002","journal-title":"Immunobiology"},{"issue":"3","key":"10.1016\/j.imbio.2023.152413_b1225","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1038\/cmi.2015.54","article-title":"Getting over our Immune-Complex \u2013 C5a receptor blockade is the answer","volume":"14","author":"Thurman","year":"2017","journal-title":"Cellular & Molecular Immunology"},{"key":"10.1016\/j.imbio.2023.152413_b1230","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.4049\/jimmunol.176.3.1305","article-title":"The central role of the alternative complement pathway in human disease","volume":"176","author":"Thurman","year":"2006","journal-title":"The Journal of Immunology"},{"issue":"3","key":"10.1016\/j.imbio.2023.152413_b1235","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1111\/cei.13515","article-title":"The rise of complement in ANCA-associated vasculitis: from marginal player to target of modern therapy","volume":"202","author":"Trivioli","year":"2020","journal-title":"Clinical and Experimental Immunology"},{"issue":"9","key":"10.1016\/j.imbio.2023.152413_b1240","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1177\/1087057109341407","article-title":"C5a-Stimulated recruitment of \u00df-arrestin2 to the nonsignaling 7-transmembrane decoy receptor C5L2","volume":"14","author":"Van Lith","year":"2009","journal-title":"Journal of Biomolecular Screening"},{"issue":"D1","key":"10.1016\/j.imbio.2023.152413_b1245","doi-asserted-by":"crossref","first-page":"D439","DOI":"10.1093\/nar\/gkab1061","article-title":"AlphaFold Protein Structure Database: massively expanding the structural coverage of protein-sequence space with high-accuracy models","volume":"50","author":"Varadi","year":"2022","journal-title":"Nucleic Acids Research"},{"issue":"1","key":"10.1016\/j.imbio.2023.152413_b1250","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.drudis.2014.09.004","article-title":"Turning mirror-image oligonucleotides into drugs: the evolution of Spiegelmer\u00ae therapeutics","volume":"20","author":"Vater","year":"2015","journal-title":"Drug Discovery Today"},{"issue":"6","key":"10.1016\/j.imbio.2023.152413_b1255","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.4049\/jimmunol.1701638","article-title":"T Cell expression of C5a receptor 2 augments murine regulatory T cell (Treg) generation and Treg-dependent cardiac allograft survival","volume":"200","author":"Verghese","year":"2018","journal-title":"The Journal of Immunology"},{"issue":"12","key":"10.1016\/j.imbio.2023.152413_b1260","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1093\/rheumatology\/kem222","article-title":"Blocking the receptor for C5a in patients with rheumatoid arthritis does not reduce synovial inflammation","volume":"46","author":"Vergunst","year":"2007","journal-title":"Rheumatology"},{"issue":"7","key":"10.1016\/j.imbio.2023.152413_b1265","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1016\/j.ajpath.2014.04.004","article-title":"High expression of C5L2 correlates with high proinflammatory cytokine expression in advanced human atherosclerotic plaques","volume":"184","author":"Vijayan","year":"2014","journal-title":"The American Journal of Pathology"},{"issue":"4","key":"10.1016\/j.imbio.2023.152413_b1270","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1111\/cts.13213","article-title":"The anti-C5a antibody vilobelimab efficiently inhibits C5a in patients with severe COVID-19","volume":"15","author":"Vlaar","year":"2022","journal-title":"Clinical and Translational Science"},{"issue":"12","key":"10.1016\/j.imbio.2023.152413_b1275","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1016\/S2213-2600(22)00297-1","article-title":"Anti-C5a antibody (vilobelimab) therapy for critically ill, invasively mechanically ventilated patients with COVID-19 (PANAMO): A multicentre, double-blind, randomised, placebo-controlled, phase 3 trial","volume":"10","author":"Vlaar","year":"2022","journal-title":"The Lancet Respiratory Medicine"},{"issue":"5","key":"10.1016\/j.imbio.2023.152413_b1280","doi-asserted-by":"crossref","DOI":"10.1056\/EVIDoa2100066","article-title":"Terminal complement inhibitor ravulizumab in generalized myasthenia gravis","volume":"1","author":"Vu","year":"2022","journal-title":"NEJM Evidence"},{"issue":"15","key":"10.1016\/j.imbio.2023.152413_b1285","first-page":"1140","article-title":"Complement \u2013 Second of Two Parts","volume":"344","author":"Walport","year":"2001","journal-title":"English Journal"},{"issue":"2","key":"10.1016\/j.imbio.2023.152413_b1290","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1111\/sji.12132","article-title":"Increased soluble C5b\u20139 in CSF of neuromyelitis optica","volume":"79","author":"Wang","year":"2014","journal-title":"Scandinavian Journal of Immunology"},{"issue":"7","key":"10.1016\/j.imbio.2023.152413_b1295","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1359\/JBMR.050206","article-title":"Fibroblasts express RANKL and support osteoclastogenesis in a COX-2-dependent manner after stimulation with titanium particles","volume":"20","author":"Wei","year":"2005","journal-title":"Journal of Bone and Mineral Research"},{"issue":"1","key":"10.1016\/j.imbio.2023.152413_b1300","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1046\/j.1365-3083.1996.d01-272.x","article-title":"The human mast cell line HMC-1 expresses C5a receptors and responds to C5a but not to C5a(desArg)","volume":"44","author":"Werfel","year":"1996","journal-title":"Scandinavian Journal of Immunology"},{"key":"10.1016\/j.imbio.2023.152413_b1305","doi-asserted-by":"crossref","DOI":"10.1038\/s41581-023-00704-1","article-title":"Complosome \u2014 the intracellular complement system","author":"West","year":"2023","journal-title":"Nature Reviews. Nephrology"},{"issue":"6","key":"10.1016\/j.imbio.2023.152413_b1310","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1111\/bjh.12707","article-title":"Complement and cytokine response in acute Thrombotic Thrombocytopenic Purpura","volume":"164","author":"Westwood","year":"2014","journal-title":"British Journal of Haematology"},{"issue":"6","key":"10.1016\/j.imbio.2023.152413_b1315","doi-asserted-by":"crossref","first-page":"2000053","DOI":"10.1002\/prca.202000053","article-title":"Pancreatic tissue proteomics unveils key proteins, pathways, and networks associated with type 1 diabetes","volume":"14","author":"Woo","year":"2020","journal-title":"PROTEOMICS \u2013 Clinical Applications"},{"issue":"9","key":"10.1016\/j.imbio.2023.152413_b1320","doi-asserted-by":"crossref","first-page":"2476","DOI":"10.1002\/art.10449","article-title":"Antiarthritic activity of an orally active C5a receptor antagonist against antigen-induced monarticular arthritis in the rat","volume":"46","author":"Woodruff","year":"2002","journal-title":"Arthritis and Rheumatism"},{"issue":"10","key":"10.1016\/j.imbio.2023.152413_b1325","doi-asserted-by":"crossref","first-page":"5514","DOI":"10.4049\/jimmunol.171.10.5514","article-title":"A potent human C5a receptor antagonist protects against disease pathology in a rat model of inflammatory bowel disease 1","volume":"171","author":"Woodruff","year":"2003","journal-title":"The Journal of Immunology"},{"issue":"2","key":"10.1016\/j.imbio.2023.152413_b1330","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1124\/jpet.105.086835","article-title":"Increased potency of a novel complement factor 5a receptor antagonist in a rat model of inflammatory bowel disease","volume":"314","author":"Woodruff","year":"2005","journal-title":"The Journal of Pharmacology and Experimental Therapeutics"},{"issue":"14","key":"10.1016\/j.imbio.2023.152413_b1335","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1016\/j.molimm.2011.04.014","article-title":"Inhibiting the C5\u2013C5a receptor axis","volume":"48","author":"Woodruff","year":"2011","journal-title":"Molecular Immunology"},{"issue":"2","key":"10.1016\/j.imbio.2023.152413_b1340","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1172\/JCI117401","article-title":"FMLP activates Ras and Raf in human neutrophils. Potential role in activation of MAP kinase","volume":"94","author":"Worthen","year":"1994","journal-title":"The Journal of Clinical Investigation"},{"issue":"10","key":"10.1016\/j.imbio.2023.152413_b1345","doi-asserted-by":"crossref","first-page":"2834","DOI":"10.4049\/jimmunol.2000778","article-title":"Absence of the C5a Receptor C5aR2 worsens ischemic tissue injury by increasing C5aR1-mediated neutrophil infiltration","volume":"205","author":"Wu","year":"2020","journal-title":"The Journal of Immunology"},{"issue":"10","key":"10.1016\/j.imbio.2023.152413_b1350","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1111\/jth.12369","article-title":"Complement activation and mortality during an acute episode of thrombotic thrombocytopenic purpura","volume":"11","author":"Wu","year":"2013","journal-title":"Journal of Thrombosis and Haemostasis"},{"issue":"2","key":"10.1016\/j.imbio.2023.152413_b1355","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1681\/ASN.2013020143","article-title":"C5a receptor (CD88) blockade protects against MPO-ANCA GN","volume":"25","author":"Xiao","year":"2014","journal-title":"Journal of the American Society of Nephrology: JASN"},{"issue":"9","key":"10.1016\/j.imbio.2023.152413_b1360","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1016\/j.jid.2018.03.1499","article-title":"Neutrophil adhesion is a prerequisite for antibody-mediated proteolytic tissue damage in experimental models of epidermolysis bullosa acquisita","volume":"138","author":"Yu","year":"2018","journal-title":"Journal of Investigative Dermatology"},{"issue":"March","key":"10.1016\/j.imbio.2023.152413_b1365","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.imlet.2019.03.014","article-title":"Differential effects of anaphylatoxin C5a on antigen presenting cells, roles for C5aR1 and C5aR2","volume":"209","author":"Zaal","year":"2019","journal-title":"Immunology Letters"},{"issue":"1084","key":"10.1016\/j.imbio.2023.152413_b1370","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1136\/postgradmedj-2015-133281","article-title":"Pathophysiology of type 1 and type 2 diabetes mellitus: A 90-year perspective","volume":"92","author":"Zaccardi","year":"2016","journal-title":"Postgraduate Medical Journal"},{"issue":"3","key":"10.1016\/j.imbio.2023.152413_b1375","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1189\/jlb.3A0415-157R","article-title":"Complement anaphylatoxin receptors C3aR and C5aR are required in the pathogenesis of experimental autoimmune uveitis","volume":"99","author":"Zhang","year":"2016","journal-title":"Journal of Leukocyte Biology"},{"key":"10.1016\/j.imbio.2023.152413_b1380","first-page":"8193932","article-title":"The controversial C5a receptor C5aR2: its role in health and disease","volume":"2017","author":"Zhang","year":"2017","journal-title":"Journal of Immunology Research"},{"key":"10.1016\/j.imbio.2023.152413_b1385","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2019.01866","article-title":"C5a\/C5aR1 pathway is critical for the pathogenesis of psoriasis","volume":"10","author":"Zheng","year":"2019","journal-title":"Frontiers in Immunology"},{"issue":"8","key":"10.1016\/j.imbio.2023.152413_b1390","doi-asserted-by":"crossref","first-page":"10590","DOI":"10.1096\/fj.202000384R","article-title":"C5a\/C5aR1 mediates IMQ-induced psoriasiform skin inflammation by promoting IL-17A production from \u03b3\u03b4-T cells","volume":"34","author":"Zheng","year":"2020","journal-title":"The FASEB Journal"},{"issue":"11","key":"10.1016\/j.imbio.2023.152413_b1395","first-page":"643","article-title":"Use of eculizumab for atypical haemolytic uraemic syndrome and C3 glomerulopathies. Nature Reviews","volume":"8","author":"Zuber","year":"2012","journal-title":"Nephrology"},{"issue":"13\u201314","key":"10.1016\/j.imbio.2023.152413_b1400","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/S0161-5890(99)00109-1","article-title":"Expression of the anaphylatoxin C5a receptor in non-myeloid cells","volume":"36","author":"Zwirner","year":"1999","journal-title":"Molecular Immunology"}],"container-title":["Immunobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0171298523000815?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0171298523000815?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T16:53:46Z","timestamp":1759251226000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0171298523000815"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":280,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["S0171298523000815"],"URL":"https:\/\/doi.org\/10.1016\/j.imbio.2023.152413","relation":{},"ISSN":["0171-2985"],"issn-type":[{"value":"0171-2985","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The role of C5a receptors in autoimmunity","name":"articletitle","label":"Article Title"},{"value":"Immunobiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.imbio.2023.152413","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier GmbH. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"152413"}}